FDA-approved Hormones & metabolism

Cosyntropin

Cosyntropin is an ACTH(1-24) analog. It is filed in this library under hormones & metabolism, a navigation topic rather than a statement of where it acts. As a regulatory matter it has at least one product approved by the FDA.

Regulatory status

Cosyntropin has an FDA-approved product on the U.S. market, marketed as Cosyntropin under application ANDA202147.

The current label is held by Medical Purchasing Solutions, LLC.

From the FDA label

What Cosyntropin is approved to treat

INDICATIONS AND USAGE Cosyntropin for Injection is intended for use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency. Because of its rapid effect on the adrenal cortex it may be utilized to perform a 30-minute test of adrenal function (plasma cortisol response) as an office or outpatient procedure, using only 2 venipunctures (see DOSAGE AND ADMINISTRATION section). Severe hypofunction of the pituitary - adrenal axis is usually associated with subnormal plasma cortisol values but a low basal level is not per se evidence of adrenal insufficiency and does not suffice to make the diagnosis. Many patients with proven insufficiency will have normal basal levels and will develop signs of insufficiency only when stressed.Quoted from the FDA-approved prescribing information

The evidence

What has actually been published

One source on Cosyntropin, resolved to its journal of record. The title is listed so you can judge the evidence rather than take a summary on trust.

Nearby

Other peptides acting on hormones & metabolism

Markers on this pathway

What is measured when adrenal response is assessed

Cosyntropin's FDA-approved label indicates it for use as a diagnostic test of adrenal function. These are the markers clinicians use when assessing adrenal response. They are listed here so you can read about them, not as a statement that Cosyntropin changes any of them.

Not sure what applies to you?

A 60-second questionnaire, reviewed by a U.S.-licensed physician.

Find my protocol

Educational reference only. This page explains what has been published about Cosyntropin. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.

Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.

All 150 peptides